BPC-157 has become one of the most widely investigated synthetic peptides in preclinical literature over the past two decades. For laboratories exploring tissue repair, gastrointestinal biology, and neurovascular signaling, BPC-157 research continues to generate substantial interest. This guide provides a structured scientific overview of what BPC-157 is, how it was discovered, its proposed mechanisms of action, and what researchers in Canada should know when sourcing high-purity material for in vitro work.
What Is BPC-157?
BPC-157, short for Body Protection Compound-157, is a synthetic pentadecapeptide consisting of 15 amino acids. Its sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. This sequence is a partial fragment derived from a larger protein identified in human gastric juice, commonly referred to as "body protection compound" or BPC.
Because the 15-residue fragment demonstrated notable stability and bioactivity in early preclinical models, it was designated BPC-157 and became the focus of a growing body of laboratory research. Unlike many peptides that degrade rapidly in gastric fluid, BPC-157 has been reported in the literature to remain stable in human gastric juice for extended periods, a property that has made it attractive for a range of in vivo rodent studies.
Discovery and Historical Context
The characterization of BPC-157 is largely credited to research groups in Croatia beginning in the early 1990s, with Professor Predrag Sikiric and colleagues at the University of Zagreb publishing extensively on its preclinical profile. Their work, indexed across PubMed, laid the foundation for subsequent investigations into angiogenic signaling, tendon and ligament models, and gut barrier integrity.
Molecular Structure and Properties
BPC-157 is a linear peptide with a molecular formula of approximately C62H98N16O22 and a molecular weight near 1419.5 g/mol. As a small, unmodified peptide, it lacks disulfide bridges or cyclization, which simplifies solid-phase peptide synthesis and quality control. High-purity lots produced via Fmoc chemistry and verified by HPLC and mass spectrometry typically exceed 98 percent purity.
The acetate salt form is the most common presentation for research material. It is highly soluble in bacteriostatic water and sterile saline, making reconstitution straightforward for cell culture experiments and preclinical protocols.
Half-Life and Stability
Pharmacokinetic studies in rodents suggest that BPC-157 has a relatively short circulating half-life, typically estimated in the range of minutes to a few hours depending on the route of administration. Despite this, its biological effects in preclinical models appear to persist longer than plasma levels would suggest.
Storage Requirements
Lyophilized BPC-157 is generally stable when stored at minus 20 degrees Celsius or colder, protected from light and moisture. Once reconstituted, researchers typically store working solutions at 2 to 8 degrees Celsius for short-term use, or aliquot and freeze for extended storage. Repeated freeze-thaw cycles should be minimized.
Proposed Mechanisms of Action
Angiogenesis and VEGFR2 Signaling
Multiple in vitro studies show that BPC-157 modulates vascular endothelial growth factor receptor 2 (VEGFR2) signaling, which is central to angiogenesis. Hsieh et al., "Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation" (J Mol Med, 2017), reported that BPC-157 promoted endothelial tube formation and increased VEGFR2 expression in cultured cells.
Nitric Oxide Pathway Modulation
Research suggests BPC-157 interacts with the nitric oxide system. Preclinical studies have reported that BPC-157 counteracts the effects of NO synthase inhibitors such as L-NAME in rodent models, suggesting it may support NO-mediated vasodilation.
Growth Factor Expression
In tendon fibroblast cultures, BPC-157 has been reported to upregulate growth hormone receptor expression. Chang et al. (2014) published findings in the Journal of Applied Physiology indicating that BPC-157 increased growth hormone receptor expression in isolated rat Achilles tendon fibroblasts.
Categories of BPC-157 Research
Tendon, Ligament, and Musculoskeletal Models
Rat Achilles tendon transection models and ligament injury models represent some of the most frequently published areas. Studies indicate BPC-157 may influence fibroblast outgrowth, collagen organization, and biomechanical recovery parameters in these systems.
Gastrointestinal and Gut Barrier Studies
Given its origin as a fragment of a gastric protein, a large body of BPC-157 research focuses on gut biology. Preclinical models have examined BPC-157 in the context of mucosal integrity, colitis models, and esophageal research.
Neuroprotection and CNS Research
More recent literature has explored BPC-157 in neuroprotection studies, including rodent models of traumatic brain injury, spinal cord research, and neuromuscular junction models.
Why Canadian Researchers Choose BPC-157
Canadian research institutions, from university biochemistry departments to independent preclinical laboratories, have shown growing interest in BPC-157 as a multi-pathway probe compound. Its relative stability, straightforward reconstitution, and broad preclinical footprint make it a practical choice for pilot studies in vascular biology, regenerative models, and gastrointestinal research.
At Based Peptides, we work with Canadian laboratories that require consistent lot-to-lot quality and timely delivery. Sourcing within Canada helps maintain chain of custody, supports reproducibility, and simplifies procurement workflows.
Sourcing Research-Grade BPC-157 in Canada
For Canadian laboratories planning BPC-157 research, quality control is non-negotiable. Researchers should look for suppliers who provide HPLC purity data, mass spectrometry confirmation of sequence, and clear labeling of peptide content. Based Peptides maintains quality documentation for all catalog items and ships across Canada with appropriate packaging.
If your lab is preparing a BPC-157 study, you can Buy BPC-157 in Canada directly from our research catalog. We also stock related compounds frequently used in comparative studies, including TB-500 and CJC-1295 DAC.
Summary
BPC-157 is a 15-amino-acid synthetic peptide derived from a gastric protection protein, with a preclinical research profile spanning angiogenesis, growth factor signaling, and gut barrier biology. Its stability, solubility, and multi-pathway activity have made it a recurring subject of laboratory investigation, and the volume of BPC-157 research continues to grow year over year.
Research Use Only Disclaimer: All peptides sold by Based Peptides are intended strictly for in vitro laboratory research and preclinical investigation by qualified professionals. They are not drugs, supplements, or cosmetics. They are not intended for human or veterinary use, diagnosis, treatment, cure, or prevention of any disease.